COMMUNIQUÉS West-GlobeNewswire

Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk
06/05/2026
MOUNTAIN VIEW, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Diathrive Health, the leader in chronic disease management, and AliveCor, the global leader in AI-powered cardiology, today announced a strategic partnership to [...]
Growth in revenue and operating profit
06/05/2026
Trading statement for Q3 2025/26 (1 January – 31 March 2026) Growth in revenue and operating profit ChemoMetec’s revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK 124.2 million in the [...]
Renewa Micro-Infusion System Claims Evaluated: The Painless Skin Microneedling Device for At-Home Face Lift Treatment
06/05/2026
How the Renewa Skin 0.3mm Gold-Needle Micro-Infusion Device Is Designed for Fine Lines, Skin Firmness, and At-Home Cosmetic Skincare for Women Over 50 in 2026 Sheridan, WY, May 06, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Interim Report Q1 2026: Navigating challenging markets in EMEA and taking actions to adjust the cost structure for future healthy margins
06/05/2026
Highlights Following the announcement of GN Store Nord’s divestment of its Hearing division, the financial performance related hereto is treated as discontinued operations in the Q1 2026 report and until closing of the [...]
Guidance updated to reflect Hearing business being treated as discontinued operations
06/05/2026
Following the company announcement on March 16, 2026 (“GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion”), GN is now reintroducing a profitability guidance for [...]
Sage Dental Expands National Reach Through Strategic Partnership with Curaechoice
06/05/2026
Partnership enhances access to affordable, comprehensive dental care for members and their families across the Southeast and beyond Birmingham, Alabama, May 06, 2026 (GLOBE NEWSWIRE) -- Sage Dental, a premier dental [...]
CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
06/05/2026
BUBENDORF, Switzerland, May 06, 2026 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS , a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, today announces its [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/05/2026
Nantes, le 6 mai 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
Robotic Companion Pets from Ageless Innovation Reach 750,000 Adoptions Supporting Well-Being for Older Adults
06/05/2026
Ageless Innovation marks a major milestone highlighting its ongoing commitment to older adults and caregivers through the power of play PAWTUCKET, R.I., May 06, 2026 (GLOBE NEWSWIRE) -- Ageless Innovation, a global [...]
Trethera To Present Optic Neuritis Research at Los Angeles Bioscience Ecosystem Summit 2026
06/05/2026
LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, autoimmune, and neuroimmune diseases, will [...]
Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours
06/05/2026
TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada, the country’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide, is proud to award $75,000 to first-of- [...]
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
06/05/2026
Reaffirmed FDA alignment on TSHA-102 BLA pathway, including pivotal trial design, endpoints and potential to submit for approval based on REVEAL pivotal trial 6-month interim analysis, following recent breakthrough [...]
Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform
06/05/2026
Transaction marks one of the first clinical-stage oncology acquisitions sourced, evaluated, and executed through an AI-powered drug development platform NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Pathos AI, a clinical- [...]
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
06/05/2026
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
06/05/2026
Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) evaluating Atrioventricular Interval Modulation Therapy (“ [...]
Cannara Completes Acquisition of Medican Organic Inc.
06/05/2026
MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Cannara complète l’acquisition de Medican Organic Inc.
06/05/2026
MONTRÉAL, 06 mai 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité supérieure [...]
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
06/05/2026
ZUSDURI™ generated revenue of $29.2 million in Q1 2026, representing 109% quarter-over-quarter growth, reflecting broader utilization with the permanent J Code effective January 1, 2026 JELMYTO achieved $21.7 million in [...]

Pages